OncoImmune’s drug lowers death risk in Phase III Covid-19 trial
Saccovid aided faster recovery in hospitalised Covid-19 patients. Image credit: Matt from Pixabay.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more